Sumitomo Mitsui Trust Holdings Inc. Has $36.77 Million Stake in Avantor, Inc. (NYSE:AVTR)

Sumitomo Mitsui Trust Holdings Inc. trimmed its position in shares of Avantor, Inc. (NYSE:AVTR) by 1.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,610,588 shares of the company’s stock after selling 29,700 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Avantor were worth $36,770,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Fifth Third Bancorp grew its holdings in Avantor by 125.3% during the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after buying an additional 694 shares in the last quarter. Quarry LP grew its holdings in Avantor by 815.3% during the first quarter. Quarry LP now owns 1,437 shares of the company’s stock worth $30,000 after buying an additional 1,280 shares in the last quarter. CKW Financial Group bought a new stake in Avantor during the fourth quarter worth $55,000. Park Place Capital Corp grew its holdings in Avantor by 18.2% during the third quarter. Park Place Capital Corp now owns 3,039 shares of the company’s stock worth $64,000 after buying an additional 467 shares in the last quarter. Finally, ORG Partners LLC bought a new stake in Avantor during the fourth quarter worth $89,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on AVTR shares. Raymond James upped their price target on Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a report on Friday, January 26th. Robert W. Baird upped their price objective on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Thursday, February 15th. Royal Bank of Canada upped their price objective on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a research note on Thursday, February 15th. UBS Group upped their price objective on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $26.71.

Avantor Stock Down 0.8 %

AVTR stock opened at $24.10 on Friday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61. The company has a market capitalization of $16.35 billion, a price-to-earnings ratio of 50.21, a PEG ratio of 2.47 and a beta of 1.37. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $26.16. The stock has a fifty day moving average of $24.93 and a 200-day moving average of $22.47.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. The company had revenue of $1.72 billion during the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The firm’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.32 EPS. As a group, equities research analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.